• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

树枝状核多壳层纳米粒子与人类红细胞相互作用的研究

Investigation on the Interaction of Dendritic Core Multi-Shell Nanoparticles with Human Red Blood Cells.

作者信息

Krauß Jakob, Georgieva Radostina, Karabaliev Miroslav, Hackmann Moritz, Rerkshanandana Pichayut, Chaiwaree Saranya, Kalus Ulrich, Pruß Axel, Xiong Yu, Bäumler Hans

机构信息

Institute of Transfusion Medicine, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany.

Department of Medical Physics, Biophysics & Radiology, Medical Faculty, Trakia University, 6000 Stara Zagora, Bulgaria.

出版信息

Nanomaterials (Basel). 2025 Jan 24;15(3):187. doi: 10.3390/nano15030187.

DOI:10.3390/nano15030187
PMID:39940163
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11820349/
Abstract

The use of nanoparticles is becoming increasingly apparent in a growing number of medical fields. To exploit the full potential of these particles, it is essential to examine their behavior in the blood and their possible interactions with blood cells. Dendritic core multi-shell DendroSol™ nanoparticles (DS-NPs) are able to penetrate into viable layers of human skin, but nothing is known about their interaction with blood cells. In the present study, we analyze the effect of DS-NPs on red blood cells (RBCs) using confocal laser scanning microscopy (CLSM), flow cytometry, sedimentation rate analysis, spectrophotometry, and hemolysis assays. DS-NPs labeled with Nile red (NR) were added to RBC suspensions and their accumulation in the area of the RBC membranes was demonstrated by CLSM as well as by flow cytometry. In the presence of DS-NPs, the RBCs show an increased sedimentation rate, which also confirms the binding of the NPs to the cells. Interestingly, in the presence of DS-NPs, the RBCs are stabilized against hypotonic hemolysis as well as against the hemolytic action of Triton X-100. This proven anti-hemolytic effect could be utilized to enhance the circulation time of RBCs loaded with drugs for prolonged sustained release and drug delivery with enhanced bioavailability.

摘要

纳米颗粒在越来越多的医学领域中的应用正变得日益明显。为了充分发挥这些颗粒的潜力,研究它们在血液中的行为以及它们与血细胞可能的相互作用至关重要。树枝状核多壳层DendroSol™纳米颗粒(DS-NPs)能够穿透人皮肤的活性层,但关于它们与血细胞的相互作用却一无所知。在本研究中,我们使用共聚焦激光扫描显微镜(CLSM)、流式细胞术、沉降率分析、分光光度法和溶血试验来分析DS-NPs对红细胞(RBCs)的影响。将用尼罗红(NR)标记的DS-NPs添加到RBC悬浮液中,CLSM和流式细胞术均证实了它们在RBC膜区域的积累。在DS-NPs存在的情况下,RBC的沉降率增加,这也证实了纳米颗粒与细胞的结合。有趣的是,在DS-NPs存在的情况下,RBC对低渗溶血以及Triton X-100的溶血作用具有稳定性。这种已证实的抗溶血作用可用于延长载药RBC的循环时间,以实现延长的持续释放和提高生物利用度的药物递送。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75ff/11820349/1c4a0e9f7ade/nanomaterials-15-00187-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75ff/11820349/f83083fa5728/nanomaterials-15-00187-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75ff/11820349/2f30b1be0957/nanomaterials-15-00187-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75ff/11820349/0fb18f5921ff/nanomaterials-15-00187-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75ff/11820349/0902754612e3/nanomaterials-15-00187-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75ff/11820349/b7716ea5d48d/nanomaterials-15-00187-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75ff/11820349/00b1a7f15e50/nanomaterials-15-00187-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75ff/11820349/1c4a0e9f7ade/nanomaterials-15-00187-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75ff/11820349/f83083fa5728/nanomaterials-15-00187-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75ff/11820349/2f30b1be0957/nanomaterials-15-00187-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75ff/11820349/0fb18f5921ff/nanomaterials-15-00187-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75ff/11820349/0902754612e3/nanomaterials-15-00187-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75ff/11820349/b7716ea5d48d/nanomaterials-15-00187-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75ff/11820349/00b1a7f15e50/nanomaterials-15-00187-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75ff/11820349/1c4a0e9f7ade/nanomaterials-15-00187-g007.jpg

相似文献

1
Investigation on the Interaction of Dendritic Core Multi-Shell Nanoparticles with Human Red Blood Cells.树枝状核多壳层纳米粒子与人类红细胞相互作用的研究
Nanomaterials (Basel). 2025 Jan 24;15(3):187. doi: 10.3390/nano15030187.
2
Surface-modified loaded human red blood cells for targeting and delivery of drugs.表面修饰负载人红细胞用于药物靶向和递送。
J Microencapsul. 2012;29(1):9-20. doi: 10.3109/02652048.2011.629741. Epub 2011 Oct 31.
3
Polystyrene Nanoparticles Activate Erythrocyte Aggregation and Adhesion to Endothelial Cells.聚苯乙烯纳米颗粒激活红细胞聚集并促进其与内皮细胞的黏附。
Cell Biochem Biophys. 2016 Mar;74(1):19-27. doi: 10.1007/s12013-015-0705-6.
4
pH-sensitive Eudragit® L 100 nanoparticles promote cutaneous penetration and drug release on the skin.pH 敏感型 Eudragit® L 100 纳米粒促进药物在皮肤中的渗透和释放。
J Control Release. 2019 Feb 10;295:214-222. doi: 10.1016/j.jconrel.2018.12.045. Epub 2018 Dec 28.
5
Light/pH-Triggered Biomimetic Red Blood Cell Membranes Camouflaged Small Molecular Drug Assemblies for Imaging-Guided Combinational Chemo-Photothermal Therapy.光/pH 触发仿生红细胞膜伪装小分子药物组装体用于影像引导联合化疗-光热治疗。
ACS Appl Mater Interfaces. 2019 May 1;11(17):15262-15275. doi: 10.1021/acsami.9b00897. Epub 2019 Apr 17.
6
VE-Albumin Core-Shell Nanoparticles for Paclitaxel Delivery to Treat MDR Breast Cancer.VE-白蛋白核壳纳米粒用于紫杉醇递药治疗多药耐药乳腺癌。
Molecules. 2018 Oct 25;23(11):2760. doi: 10.3390/molecules23112760.
7
Nanoparticle Properties Modulate Their Attachment and Effect on Carrier Red Blood Cells.纳米颗粒性质调节其对载体红细胞的附着和作用。
Sci Rep. 2018 Jan 25;8(1):1615. doi: 10.1038/s41598-018-19897-8.
8
Monodisperse Rattle-Structured Gold Nanorod-Mesoporous Silica Nanoparticles Core-Shell as Sulforaphane Carrier and its Sustained-Release Property.单分散响尾蛇结构金纳米棒-介孔二氧化硅纳米粒子核壳作为萝卜硫素载体及其缓释性能
Drug Res (Stuttg). 2018 Sep;68(9):504-513. doi: 10.1055/a-0573-8966. Epub 2018 Apr 16.
9
Core-shell type lipid/rPAA-Chol polymer hybrid nanoparticles for in vivo siRNA delivery.用于体内 siRNA 递送的核壳型脂质/rPAA-Chol 聚合物杂化纳米粒子。
Biomaterials. 2014 Feb;35(6):2066-78. doi: 10.1016/j.biomaterials.2013.11.046. Epub 2013 Dec 7.
10
Albumin-Albumin/Lactosylated Core-Shell Nanoparticles: Therapy to Treat Hepatocellular Carcinoma for Controlled Delivery of Doxorubicin.白蛋白-乳糖化核壳纳米粒子:用于治疗肝细胞癌的治疗方法,用于控制阿霉素的递送。
Molecules. 2020 Nov 20;25(22):5432. doi: 10.3390/molecules25225432.

本文引用的文献

1
Current approaches of nanomedicines in the market and various stage of clinical translation.市场上纳米药物的当前方法以及临床转化的各个阶段。
Acta Pharm Sin B. 2022 Jul;12(7):3028-3048. doi: 10.1016/j.apsb.2022.02.025. Epub 2022 Mar 1.
2
Application Perspectives of Nanomedicine in Cancer Treatment.纳米医学在癌症治疗中的应用前景
Front Pharmacol. 2022 Jul 1;13:909526. doi: 10.3389/fphar.2022.909526. eCollection 2022.
3
Red Blood Cell Inspired Strategies for Drug Delivery: Emerging Concepts and New Advances.红细胞启发的药物递送策略:新兴概念和新进展。
Pharm Res. 2022 Nov;39(11):2673-2698. doi: 10.1007/s11095-022-03328-5. Epub 2022 Jul 7.
4
Recent Progress in Red Blood Cells-Derived Particles as Novel Bioinspired Drug Delivery Systems: Challenges and Strategies for Clinical Translation.红细胞衍生颗粒作为新型仿生药物递送系统的研究进展:临床转化面临的挑战与策略
Front Chem. 2022 Apr 27;10:905256. doi: 10.3389/fchem.2022.905256. eCollection 2022.
5
Current advances in nanomaterials affecting morphology, structure, and function of erythrocytes.纳米材料在影响红细胞形态、结构和功能方面的当前进展。
RSC Adv. 2021 Feb 10;11(12):6958-6971. doi: 10.1039/d0ra10124a. eCollection 2021 Feb 4.
6
Probing the Interaction Between Supercarrier RBC Membrane and Nanoparticles for Optimal Drug Delivery.探索超级载体红细胞膜与纳米颗粒之间的相互作用以实现最佳药物递送。
J Mol Biol. 2023 Jan 15;435(1):167539. doi: 10.1016/j.jmb.2022.167539. Epub 2022 Mar 12.
7
Role of oxidative stress in nanoparticles toxicity.氧化应激在纳米颗粒毒性中的作用。
Free Radic Res. 2021 Apr;55(4):331-342. doi: 10.1080/10715762.2020.1859108. Epub 2020 Dec 18.
8
A framework for designing delivery systems.设计传递系统的框架。
Nat Nanotechnol. 2020 Oct;15(10):819-829. doi: 10.1038/s41565-020-0759-5. Epub 2020 Sep 7.
9
Tumor extravasation and infiltration as barriers of nanomedicine for high efficacy: The current status and transcytosis strategy.肿瘤外渗和浸润作为纳米医学高效性的屏障:现状和转胞吞作用策略。
Biomaterials. 2020 May;240:119902. doi: 10.1016/j.biomaterials.2020.119902. Epub 2020 Feb 18.
10
Smart cancer nanomedicine.智能癌症纳米医学。
Nat Nanotechnol. 2019 Nov;14(11):1007-1017. doi: 10.1038/s41565-019-0567-y. Epub 2019 Nov 6.